Consensus Guidelines on Rodent Models of Restless Legs Syndrome.


Journal

Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688

Informations de publication

Date de publication:
03 2021
Historique:
revised: 29 09 2020
received: 24 07 2020
accepted: 26 10 2020
pubmed: 1 1 2021
medline: 28 4 2021
entrez: 31 12 2020
Statut: ppublish

Résumé

Restless legs syndrome (RLS) is a chronic sensorimotor disorder diagnosed by clinical symptoms. It is challenging to translate the diagnostic self-reported features of RLS to animals. To help researchers design their experiments, a task force was convened to develop consensus guidelines for experimental readouts in RLS animal models. The RLS clinical diagnostic criteria were used as a starting point. After soliciting additional important clinical features of RLS, a consensus set of methods and outcome measures intent on capturing these features-in the absence of a face-to-face interview-was generated and subsequently prioritized by the task force. These were, in turn, translated into corresponding methods and outcome measures for research on laboratory rats and mice and used to generate the final recommendations. The task force recommended activity monitoring and polysomnography as principal tools in assessing RLS-like behavior in rodents. Data derived from these methods were determined to be the preferred surrogate measures for the urge to move, the principal defining feature of RLS. The same tools may be used to objectively demonstrate sleep-state features highly associated with RLS, such as sleep disturbance and number and periodicity of limb movements. Pharmacological challenges and dietary or other manipulations that affect iron availability are desirable to aggravate or improve RLS-like behavior and lend greater confidence that the animal model being proffered replicates key clinical features of RLS. These guidelines provide the first consensus experimental framework for researchers to use when developing new rodent models of RLS. © 2020 International Parkinson and Movement Disorder Society.

Identifiants

pubmed: 33382140
doi: 10.1002/mds.28401
pmc: PMC8313425
mid: NIHMS1722448
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

558-569

Subventions

Organisme : BLRD VA
ID : IK6 BX005245
Pays : United States
Organisme : NINDS NIH HHS
ID : L30 NS084422
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA034748
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL148574
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS075012
Pays : United States

Informations de copyright

© 2020 International Parkinson and Movement Disorder Society.

Références

J Neurol Sci. 2002 Jun 15;198(1-2):71-7
pubmed: 12039666
J Neurosci Methods. 2018 Apr 15;300:37-47
pubmed: 28456660
Sleep Med. 2014 Nov;15(11):1288-301
pubmed: 25201131
Sleep Med. 2003 Mar;4(2):101-19
pubmed: 14592341
Sleep Med. 2014 Aug;15(8):860-73
pubmed: 25023924
J Neurosci Methods. 2010 Nov 30;193(2):321-33
pubmed: 20817037
J Sleep Res. 2020 Jun;29(3):e12896
pubmed: 31313413
Front Physiol. 2018 Dec 17;9:1818
pubmed: 30618828
Mov Disord. 2018 Jul;33(7):1077-1091
pubmed: 29756335
Sleep. 2012 Mar 01;35(3):433-42
pubmed: 22379250
Sleep Med. 2020 Jul;71:141-148
pubmed: 32094092
Mov Disord. 2017 Dec;32(12):1687-1693
pubmed: 28843017
Neurogenetics. 2012 May;13(2):147-57
pubmed: 22457016
Hum Mol Genet. 2012 Sep 15;21(18):3984-92
pubmed: 22678064
Sleep. 2004 May 1;27(3):388-93
pubmed: 15164889
J Sleep Res. 2015 Dec;24(6):695-701
pubmed: 26118726
J Clin Psychiatry. 1997 Aug;58(8):348-50
pubmed: 9515972
Sci Rep. 2017 Jan 31;7:41698
pubmed: 28139776
J Neurol Sci. 2012 Sep 15;320(1-2):26-31
pubmed: 22704032
Neurology. 2016 Apr 5;86(14):1336-1343
pubmed: 26944272
Mov Disord. 1997 Jan;12(1):61-5
pubmed: 8990055
Sleep. 2009 Jun;32(6):772-8
pubmed: 19544754
Sleep Med. 2001 Jan;2(1):57-61
pubmed: 11152983
J Pharmacol Methods. 1989 Apr;21(2):129-40
pubmed: 2716336
PLoS One. 2012;7(4):e35538
pubmed: 22514749
Sleep Med Rev. 2012 Aug;16(4):283-95
pubmed: 21795081
Sleep. 2014 Aug 01;37(8):1383-92
pubmed: 25083019
J Sleep Res. 2017 Aug;26(4):436-443
pubmed: 28127802
J Neurosci Methods. 2016 Feb 1;259:90-100
pubmed: 26582569
Sleep Med. 2016 Oct;26:86-95
pubmed: 27890390
Elife. 2017 May 26;6:
pubmed: 28548639
Behav Brain Funct. 2009 Feb 25;5:11
pubmed: 19243583
Dis Model Mech. 2017 Aug 1;10(8):981-991
pubmed: 28645892
Sleep Med. 2013 Jul;14(7):675-84
pubmed: 23859128
J Neurosci Methods. 2019 Sep 1;325:108323
pubmed: 31255597
Neurology. 2011 Jul 12;77(2):110-7
pubmed: 21715702
J Clin Invest. 2019 Mar 26;129(7):2730-2744
pubmed: 30913037
J Neurosci Methods. 2007 Jul 30;163(2):373-83
pubmed: 17481736
Nat Commun. 2018 Aug 8;9(1):3149
pubmed: 30089879
Physiol Genomics. 2007 Jan 17;28(2):232-8
pubmed: 16985007
Mov Disord. 1998 Mar;13(2):324-9
pubmed: 9539348
Sleep. 2013 May 01;36(5):661-9
pubmed: 23633748
J Clin Sleep Med. 2016 Aug 15;12(8):1089-97
pubmed: 27306390
Lancet Neurol. 2017 Nov;16(11):898-907
pubmed: 29029846

Auteurs

Aaro V Salminen (AV)

Institute of Neurogenomics, Helmholtz Zentrum München GmbH - German Research Center for Environmental Health, Neuherberg, Germany.
Institute of Human Genetics, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

Alessandro Silvani (A)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Richard P Allen (RP)

Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA.

Stefan Clemens (S)

Department of Physiology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.

Diego Garcia-Borreguero (D)

Sleep Research Institute, Madrid, Spain.

Imad Ghorayeb (I)

Département de Neurophysiologie Clinique, Pôle Neurosciences Cliniques, CHU de Bordeaux, Bordeaux, France.
Université de Bordeaux, Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, UMR 5287, Bordeaux, France.
CNRS, Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, UMR 5287, Bordeaux, France.

Sergi Ferré (S)

National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA.

Yuqing Li (Y)

Norman Fixel Institute for Neurological Diseases, Department of Neurology, College of Medicine, University of Florida, Gainesville, Florida, USA.

William Ondo (W)

Houston Methodist Hospital Neurological Institute, Weill Cornell Medical School, Houston, Texas, USA.

Daniel L Picchietti (DL)

University of Illinois School of Medicine, Carle Illinois College of Medicine and Carle Foundation Hospital, Urbana, Illinois, USA.

David Rye (D)

Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA.

Jerome M Siegel (JM)

Neuropsychiatric Institute and Brain Research Institute, University of California, Los Angeles, Los Angeles, California, USA.
Neurobiology Research, Veterans Administration Greater Los Angeles Healthcare System, North Hills, California, USA.

John W Winkelman (JW)

Departments of Psychiatry and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Mauro Manconi (M)

Sleep Medicine Unit, Regional Hospital of Lugano, Neurocenter of Southern Switzerland, Lugano, Switzerland.
Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
Department of Neurology, University Hospital Inselspital, Bern, Switzerland.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH